Skip to main content
Top
Published in: Clinical and Experimental Medicine 4/2019

01-11-2019 | Aortic Dissection | Original Article

Lag3+ regulatory T lymphocytes in critical carotid artery stenosis

Authors: F. Del Porto, N. Cifani, M. Proietta, T. Dezi, L. Tritapepe, S. Raffa, A. Micaloni, M. Taurino

Published in: Clinical and Experimental Medicine | Issue 4/2019

Login to get access

Abstract

The aim of this study was to evaluate CD25+ and Lag3+ T regulatory subpopulations in patients with critical carotid artery stenosis (CAS) and Stanford-A acute aortic dissection (AAD). CD25+ and Lag3+ were measured in 36 patients affected by CAS and 24 patients with Stanford type A AAD. Based on neurological symptoms, patients affected by CAS were further divided in 25 asymptomatic (CAS-A) and 11 symptomatic (CAS-S) subjects. Twenty-five patients with traditional cardiovascular risk factors (RF), matched for age and sex, were used as control group. Interleukin (IL)-10, IL-6 and transforming growth factor-β-levels were also measured. CD25+ T cells were significantly increased in CAS-S versus CAS-A (p > 0.05), AAD (p > 0.05) and RF (p > 0.05). Moreover, a significant increase in Lag3+ Tregs was observed in CAS e CAS-S versus AAD (p < 0.05) and RF (p < 0.05), whereas no significant difference was observed between CAS-S and CAS-A. IL-6 was higher in AAD compared to the other groups. Patients with neurological symptoms display a peculiar expansion of CD25+ T cells, strongly confirming a relationship between ischemic brain damage and this regulatory subpopulation, whereas Lag3+ Tregs early distinguish CAS from AAD and probably exert protective actions against aortic wall rupture throughout their anti-inflammatory functions.
Literature
1.
go back to reference Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585–98.CrossRef Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007;7:585–98.CrossRef
2.
go back to reference Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.CrossRef Sakaguchi S, Yamaguchi T, Nomura T, et al. Regulatory T cells and immune tolerance. Cell. 2008;133:775–87.CrossRef
3.
go back to reference Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.
4.
go back to reference Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–42.CrossRef Groux H, O’Garra A, Bigler M, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 1997;389:737–42.CrossRef
5.
go back to reference Linterman MA, Pierson W, Lee SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17:975–82.CrossRef Linterman MA, Pierson W, Lee SK, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17:975–82.CrossRef
6.
go back to reference Lim HW, Hillsamer P, Banham AH, et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175:4180–3.CrossRef Lim HW, Hillsamer P, Banham AH, et al. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J Immunol. 2005;175:4180–3.CrossRef
7.
go back to reference Kim HJ, Verbinnen B, Tang X, et al. Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance. Nature. 2010;467:328–32.CrossRef Kim HJ, Verbinnen B, Tang X, et al. Inhibition of follicular T-helper cells by CD8+ regulatory T cells is essential for self tolerance. Nature. 2010;467:328–32.CrossRef
8.
go back to reference Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.CrossRef Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299:1057–61.CrossRef
9.
go back to reference Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;17:627–9.CrossRef Sakaguchi S, Powrie F. Emerging challenges in regulatory T cell function and biology. Science. 2007;17:627–9.CrossRef
10.
go back to reference Bacchetta R, Sartirana C, Levings MK, et al. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol. 2002;32:2237–45.CrossRef Bacchetta R, Sartirana C, Levings MK, et al. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol. 2002;32:2237–45.CrossRef
11.
go back to reference Gagliani N, Magnani CF, Huber S, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46.CrossRef Gagliani N, Magnani CF, Huber S, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med. 2013;19:739–46.CrossRef
12.
go back to reference Okamura T, Fujio K, Shibuya M, et al. CD4+ CD25− LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci USA. 2009;106:13974–9.CrossRef Okamura T, Fujio K, Shibuya M, et al. CD4+ CD25 LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci USA. 2009;106:13974–9.CrossRef
13.
go back to reference Okamura T, Sumitomo S, Morita K, et al. TGF-β3-expressing CD4+ CD25− LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329.CrossRef Okamura T, Sumitomo S, Morita K, et al. TGF-β3-expressing CD4+ CD25 LAG3+ regulatory T cells control humoral immune responses. Nat Commun. 2015;6:6329.CrossRef
14.
go back to reference Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368–80.CrossRef Gisterå A, Hansson GK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13:368–80.CrossRef
15.
go back to reference Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679–91.CrossRef Kleinschnitz C, Kraft P, Dreykluft A, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood. 2013;121:679–91.CrossRef
16.
go back to reference Del Porto F, Cifani N, Proietta M, et al. Regulatory T CD4+ CD25+ lymphocytes increase in symptomatic carotid artery stenosis. Ann Med. 2017;49:283–90.CrossRef Del Porto F, Cifani N, Proietta M, et al. Regulatory T CD4+ CD25+ lymphocytes increase in symptomatic carotid artery stenosis. Ann Med. 2017;49:283–90.CrossRef
17.
go back to reference Kaplan A, Altara R, Eid A, et al. Update on the protective role of regulatory T Cells in myocardial infarction: a promising therapy to repair the heart. J Cardiovasc Pharmacol. 2016;68:401–13.CrossRef Kaplan A, Altara R, Eid A, et al. Update on the protective role of regulatory T Cells in myocardial infarction: a promising therapy to repair the heart. J Cardiovasc Pharmacol. 2016;68:401–13.CrossRef
18.
go back to reference Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med. 2013;158:676–85.CrossRef Raman G, Moorthy D, Hadar N, et al. Management strategies for asymptomatic carotid stenosis: a systematic review and meta-analysis. Ann Intern Med. 2013;158:676–85.CrossRef
19.
go back to reference Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34:2995–8.CrossRef Kidwell CS, Warach S. Acute ischemic cerebrovascular syndrome: diagnostic criteria. Stroke. 2003;34:2995–8.CrossRef
20.
go back to reference Nakachi S, Sumitomo S, Tsuchida Y, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97.CrossRef Nakachi S, Sumitomo S, Tsuchida Y, et al. Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis. Arthritis Res Ther. 2017;19:97.CrossRef
21.
go back to reference Del Porto F, Proietta M, Tritapepe L, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42:622–9.CrossRef Del Porto F, Proietta M, Tritapepe L, et al. Inflammation and immune response in acute aortic dissection. Ann Med. 2010;42:622–9.CrossRef
Metadata
Title
Lag3+ regulatory T lymphocytes in critical carotid artery stenosis
Authors
F. Del Porto
N. Cifani
M. Proietta
T. Dezi
L. Tritapepe
S. Raffa
A. Micaloni
M. Taurino
Publication date
01-11-2019
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 4/2019
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-019-00570-x

Other articles of this Issue 4/2019

Clinical and Experimental Medicine 4/2019 Go to the issue